PRO MEDICUS LIMITED — Annual Report 2013

Aug 22, 2013

Rule 4.2A

Appendix 4E

Preliminary Final Report

1. Company details

Name of entity

Name of entity
	Pro Medicus Limited
ABN or equivalentcompany reference			Financial year ended('current period')		Financial year ended('previous period')
25 006 194 752			30 June 2013		30 June 2012
			2. Results for announcement to the market
ASXListingRulesRef						2013A$'000
2.1	Revenue from continuing operations			11,374
		the previous corresponding period.	% change up/(down) of revenue from ordinary activities from			Down0.04%
2.2			Profit after tax attributable to members			5,131
		corresponding period.	% change up/(down) of Profit/(Loss) from ordinary activitiesafter tax attributable to members from the previous			Up186.5%
2.3			Net Profit for the period attributable to members			5,131
	period.		% change up/(down) of Net Profit/(Loss) for the periodattributable to members from the previous corresponding			Up186.5%

2.4	Dividends (distributions)	Amount persecurity	Fully Frankedamount persecurity
	Franked dividend amount per security
	Final Dividend	1.0 cents	1.0 cents
	Interim dividend	1.0 cents	1.0 cents
2.5	Record date for Final dividends	13 September 2013
	Payment date for Final dividends	4 October 2013

2.6	Australia
	The Group employs 28 people in Australia who undertake research and development of Pro Medicusproducts (RIS) as well as sales and service/support functions.
	The Group's Australian revenue was marginally above last year's result despite an increasinglycompetitive local market with overall profit being affected by increased costs associated with theongoing commercialisation and rollout of the Company's new Coral RIS technology platform.
	Promedicus.net, the company's e-health offering, continued to hold its strong market position despiteincreasing competition.
	North America
	The Group employs 8 people in North America to fulfil the sales marketing and professional servicesroles. Revenue from North America increased by 26.9% compared to the previous year. This waslargely attributable to an increase in transaction based revenue from sales of Visage technology asmore contracts come on stream as well as an increase in Original Equipment Manufacturer (OEM)sales.
	Europe
	Pro Medicus established a presence in Europe with the acquisition of Visage Imaging GmbH in lateJanuary 2009. The group has 38 employees in its Berlin office who undertake research anddevelopment of Visage Imaging products worldwide as well as sales, marketing and service/supportfunctions for the group's European operations. Revenue from our European operations decreased by22.6% compared to the previous year due to deteriorating European market conditions.
	Financials
	Full year revenue of the Group from continuing operations, decreased marginally from $11.38m to$11.37m, a decrease of 0.4%.
	The result from the underlying operations for the year was a loss of $0.65m. The underlying loss ismade up of reported profit after-tax of $5.13m, less the after-tax profit of $8.61m of Amira and after-taxnet currency gain of $0.39m, and adding back the after-tax impairment expense of $3.22m. Thisresult was impacted by additional costs, mainly associated with the ongoing commercialisation and rollout of Coral RIS to the market
	Profit after tax for the period was $5.13m an increase of 186.5% from the previous year.
	The key driver of the profit increase was the sale of Amira business in July 2012 which generated aone-off after-tax profit of $8.61m. This was partially offset by a decrease in the carrying value of somethe company's intangible assets which resulted in an after-tax impairment loss of $3.22m.
	Shareholder Returns
	The directors are confident that the holdings of reserve cash is sufficient to underpin the developmentand expansion needs of the company as the business looks to increase its penetration of existingmarkets.
3.	Statement of Comprehensive Income
	Please refer to the Statement of Comprehensive Income in the attached FinancialStatements.
4.	Statement of Financial Position
	Please refer to the Statement of Financial Position in the attached Financial Statements.
5.	Statement of cash flows
	Please refer to the Statement of cash flows in the attached Financial Statements.

6.	Details of Dividends
		2013$'000	2012$'000
	Final Dividend
	A Final Dividend of 1.0 cents (2012: 1.0 cents) per sharefully franked will be paid on 4th October 2013.	1,002	1,002
	Current Year Interim
	An interim dividend of 1.0 cents (2012: 0.50 cents) pershare fully franked was paid on 22 March 2013.	1,002	501
	No foreign sourced dividend or distribution is included in either the interim or finaldividends.
7.	Dividend or Distribution reinvestment plans
	There are no dividend or distribution reinvestment plans in operation.
8.	Statement of Retained Earnings
	Please refer to Statement of Changes in Equity in the attached Financial Statements.
9.	Net Tangible Assets per security	2013	2012
	Net Tangible Assets per security	$0.15	$0.05
10.	Details of entities over which control has been gained or lost during theperiod
	There are no entities over which control has been gained or lost during the period
11.	Associates and joint venture entities
	There are no associates or joint venture entities
12.	Other significant information needed by an investor to make an informedassessment of the entity's financial performance and financial position.
	Please refer to section 2.6
13.	Foreign Entity accounting standards
	Australian Accounting Standards & International Financial Reporting Standards

14.	Commentary on results for the period.The earnings per security and the nature of any dilution aspects.Please refer to Note 9 of the attached Financial Statements.
	Returns to shareholders including distributions and buy backs.Please refer to Note 10 of the attached Financial Statements.
	Significant features of operating performance.Please refer to section 2.6.
	The results of segments that are significant to an understanding of the business.Please refer to Note 5 of the attached Financial Statements.
	Discussion of trends in performance.Please refer to section 2.6.
15.	Audit Statement
	This report is based on accounts to which one of the following applies.(Tick one)+The +Theaccountshavebeenaccounts have been subject toaudited.review.
	+The +Theaccountsareintheaccounts have not yet beenprocess of being audited.audited or reviewed.

Sign here: Date: 23 August 2013

Print name: Sam Hupert Chief Executive Officer